![](https://investorshub.advfn.com/uicon/602423.png?cb=1523090996)
Wednesday, December 22, 2021 5:44:06 PM
Recent ALLK News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 12:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:08:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:06:33 PM
- Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/07/2024 08:02:00 PM
- Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile • GlobeNewswire Inc. • 06/25/2024 08:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 09:00:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/07/2024 07:43:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/06/2024 08:14:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:05:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 11:20:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 11:15:11 AM
- Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria • GlobeNewswire Inc. • 05/28/2024 11:02:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:09:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:06:00 PM
- Allakos Provides Business Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 08:02:00 PM
- Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/14/2024 08:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:05:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:22:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:52:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:05:11 PM
- Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024 • GlobeNewswire Inc. • 02/26/2024 12:02:00 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM